MedPath

海南爱科制药有限公司

Ownership
-
Established
2002-08-21
Employees
-
Market Cap
-
Website
www.aikepharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20254524
Approval Date
Jun 10, 2025
NMPA

Nefopam Hydrochloride Injection

Product Name
盐酸奈福泮注射液
Approval Number
国药准字H20254330
Approval Date
May 27, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20254212
Approval Date
May 20, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20254213
Approval Date
May 20, 2025
NMPA

Fluconazole and Sodium Chloride Injection

Product Name
氟康唑氯化钠注射液
Approval Number
国药准字H20253965
Approval Date
Apr 22, 2025
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H43022002
Approval Date
Oct 13, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H43022006
Approval Date
Oct 13, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H43022003
Approval Date
Oct 13, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H43022001
Approval Date
Oct 13, 2020
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H43020392
Approval Date
Oct 13, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.